Suppr超能文献

间充质干细胞衍生外泌体作为潜在治疗平台的替代方案。

Alternatives of mesenchymal stem cell-derived exosomes as potential therapeutic platforms.

作者信息

Lee Sihun, Jung Se Young, Yoo Donghyeon, Go Dabin, Park Ji Yeong, Lee Jong Min, Um Wooram

机构信息

Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.

出版信息

Front Bioeng Biotechnol. 2024 Sep 9;12:1478517. doi: 10.3389/fbioe.2024.1478517. eCollection 2024.

Abstract

With outstanding therapeutic potential in the tissue regeneration and anti-inflammation, mesenchymal stem cell-derived exosomes (MSC-EXOs) have emerged as a prominent therapeutic in recent. However, poor production yield and reproducibility have remained as significant challenges of their practical applications. To surmount these challenges, various alternative materials with stem cell-like functions, have been recently investigated, however, there has been no comprehensive analysis in these alternatives so far. Here, we discuss the recent progress of alternatives of MSC-EXOs, including exosomes and exosome-like nanovesicles from various biological sources such as plants, milk, microbes, and body fluids. Moreover, we extensively compare each alternative by summarizing their unique functions and mode of actions to suggest the expected therapeutic target and future directions for developing alternatives for MSC-EXOs.

摘要

间充质干细胞衍生的外泌体(MSC-EXOs)在组织再生和抗炎方面具有出色的治疗潜力,近年来已成为一种重要的治疗手段。然而,产量低和可重复性差仍然是其实际应用中的重大挑战。为了克服这些挑战,最近人们研究了各种具有干细胞样功能的替代材料,然而,到目前为止,尚未对这些替代材料进行全面分析。在此,我们讨论了MSC-EXOs替代物的最新进展,包括来自植物、牛奶、微生物和体液等各种生物来源的外泌体和类外泌体纳米囊泡。此外,我们通过总结它们的独特功能和作用方式,对每种替代物进行了广泛比较,以提出预期的治疗靶点以及开发MSC-EXOs替代物的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d70/11417005/a4b8193aaf68/fbioe-12-1478517-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验